Actively Recruiting
The Effect of Melatonin Supplementation on Cumulus Cells and IVF Outcomes
Led by Kaohsiung Veterans General Hospital. · Updated on 2024-08-13
200
Participants Needed
1
Research Sites
243 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study investigates the effects of melatonin supplementation on cumulus cell gene expression and in vitro fertilization (IVF) outcomes in women over 35 years old. In the study group, patients will receive melatonin supplementation for at least two months prior to their IVF cycles. Cumulus cells will be collected after oocyte retrieval, and IVF outcomes will be assessed.
CONDITIONS
Official Title
The Effect of Melatonin Supplementation on Cumulus Cells and IVF Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 35-45 years
- BMI 18-30 kg/m2
- Planning to undergo IVF cycles
You will not qualify if you...
- Primary ovarian insufficiency
- History of oophorectomy
- Receiving oocyte donation
- Chromosome anomaly
- Congenital uterine anomaly
- Severe intrauterine adhesion
- Malignancy
- Using hormone therapy or supplements in recent 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
Kaohsiung City, Taiwan, 886
Actively Recruiting
Research Team
L
Li-Te Lin
CONTACT
K
Kuan-Hao Tsui
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here